Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel J. Jackson, M.D.
University of Wisconsin School of Medicine and Public Health; Division of Allergy & Immunology
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital Colorado: Allergy Program
Aurora, Colorado, United States
- Children'S National Medical Center: Children'S Research Institute
Washington D.C., District of Columbia, United States
- Ann & Robert H. Lurie Children'S Hospital of Chicago: Division of Allergy and Immunology
Chicago, Illinois, United States
- Boston Children'S Hospital: Department of Immunology
Boston, Massachusetts, United States
- Washington University at St. Louis
St Louis, Missouri, United States
- Columbia University Medical Center: Division of Pediatric Pulmonology
New York, New York, United States
- Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute
New York, New York, United States
- Cincinnati Children'S Hospital Medical Center: Asthma Center
Cincinnati, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 May 2022
- Primary completion
- 31 Dec 2026
- Completion
- 15 Mar 2027
- Last update posted
- 20 Jan 2026
- Registered enrollment
- 240
- Registry id
- NCT05347771
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.